GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » EBITDA Margin %

Nobel Biocare Holding AG (Nobel Biocare Holding AG) EBITDA Margin % : 16.11% (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nobel Biocare Holding AG's EBITDA for the six months ended in Dec. 2013 was $125.1 Mil. Nobel Biocare Holding AG's Revenue for the six months ended in Dec. 2013 was $776.4 Mil. Therefore, Nobel Biocare Holding AG's EBITDA margin for the quarter that ended in Dec. 2013 was 16.11%.


Nobel Biocare Holding AG EBITDA Margin % Historical Data

The historical data trend for Nobel Biocare Holding AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG EBITDA Margin % Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.78 24.47 17.96 17.45 16.11

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.78 24.47 17.96 17.45 16.11

Competitive Comparison of Nobel Biocare Holding AG's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's EBITDA Margin % falls into.



Nobel Biocare Holding AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nobel Biocare Holding AG's EBITDA Margin % for the fiscal year that ended in Dec. 2013 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=125.079/776.422
=16.11 %

Nobel Biocare Holding AG's EBITDA Margin % for the quarter that ended in Dec. 2013 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2013 )/Revenue (Q: Dec. 2013 )
=125.079/776.422
=16.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG  (OTCPK:NBHGF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Nobel Biocare Holding AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines